Showing 1661-1670 of 9336 results for "".
- Crown’s Patented Xycrobe Technology Supports a Healthy Skin Microbiomehttps://practicaldermatology.com/news/crowns-patented-xycrobe-technology-supports-a-healthy-skin-microbiome/2461440/Crown Aesthetics’ BIOJUVE regimen, which incorporates the patented Xycrobe technology, supports a healthy skin environment, promotes increased skin hydration, decreases redness, regulates sebum production and reduces the appearance of signs of aging such as fine lines and photodamage, according to …
- Laser Could Prevent UV Radiation-Induced Damage to Skinhttps://practicaldermatology.com/news/laser-could-prevent-uv-radiation-induced-damage-to-skin/2461438/Incidence rates of squamous cell carcinomas (SCCs) are increasing, particularly in high-risk populations, including fair-skinned or immunosuppressed individuals. Few therapeutic options exist to prevent sunlight-induced skin cancer despite rising incidence rates. A recent study determined that abla…
- Nu Skin Launches ageLOC LumiSpa iOhttps://practicaldermatology.com/news/nu-skin-launches-ageloc-lumispa-io/2461437/Nu Skin Enterprises is introducing ageLOC LumiSpa iO system, a smart skin treatment and cleansing device with a connected, immersive experience. Featuring Nu Skin's patented micropulse technology, the new ageLOC LumiSpa iO system offers customized treatment options, intelligent coaching, skincare…
- Merz Aesthetics Now Offering the SaltFacial by SaltMEDhttps://practicaldermatology.com/news/merz-aesthetics-now-offering-the-saltfacial-by-saltmed/2461433/Merz Aesthetics and SaltMED are extending their commercial agreement adding The SaltFacial by SaltMED to the portfolio of products offered by Merz Aesthetics. The SaltFacial is a skin rejuvenation system that targets the texture, tone ,and color of skin. The SaltFacial features three technolo…
- Case Study: Ulcer at Corner of Mouth May Be First Sign of Monkeypox Virushttps://practicaldermatology.com/news/case-study-ulcer-at-corner-of-mouth-may-be-first-sign-of-monkeypox-virus/2461429/Recent infection with monkeypox virus may initially present with an ulcer at the corner of the mouth, according to a case study of a 51-year-old HIV-positive patient published in Deutsches Ärzteblatt international. The patient presented to his general practitioner with a vesicle at the left corne…
- Score: Droplette Micro-infuser Named one of Time Magazine's Best Inventions of 2022https://practicaldermatology.com/news/score-droplette-micro-infuser-named-one-of-time-magazines-best-inventions-of-2022/2461427/Droplette’s Micro-Infuser Device is one of TIME’s Best Inventions of 2022. The annual list recognizes the 200 innovations that have significantly impacted the way we live. As it profoundly enhances drug delivery into the skin, Droplette’s microinfusion technology was initially developed to painl…
- Revance Shares Two Publications in The Aesthetic Surgery Journal That Advance Glabellar Line Injection Technique and Assessmenthttps://practicaldermatology.com/news/revance-shares-two-publications-in-the-aesthetic-surgery-journal-that-advance-glabellar-line-injection-technique-and-assessment/2461425/Two peer-reviewed articles in the Aesthetic Surgery Journal, the official journal of The Aesthetic Society, highlight the nuances of glabellar line injection technique and aim to improve patient outcomes, irrespective of the neuromodulator used. The first publication demonstrates the impact of subt…
- ACR Study: Belimumab Improves CLE Toohttps://practicaldermatology.com/news/acr-study-belimumab-improves-cle/2461423/The B-cell inhibitor belimumab significantly improved cutaneous lupus erythematosus (CLE) whether or not patients also had systemic lupus erythematosus (SLE), according to research presented at ACR Convergence 2022, the American College of Rheumatology’s annual meeting, Belimumab, a monoclonal an…
- Bimekizumab Demonstrated Sustained Clinical Responses to Week 52 in Phase 3 Studies in PsA, Non-Radiographic Axial Spondyloarthritis, and AShttps://practicaldermatology.com/news/bimekizumab-demonstrated-sustained-clinical-responses-to-week-52-in-phase-3-studies-in-psa-non-radiographic-axial-spondyloarthritis-and-as/2461422/Bimekizumab demonstrated sustained clinical responses to Week 52 in Phase 3 studies in psoriatic arthritis, non-radiographic axial spondyloarthritis and ankylosing spondylitis.. The findings were presented at the ACR Convergence 2022 in Philadelphia, November 10–14, 2022. In BE OPTIMAL, clinical …
- High Rates of Skin Conditions Seen Among Urban-living Indigenous Kids in High-Income Countrieshttps://practicaldermatology.com/news/high-rates-of-skin-conditions-seen-among-urban-living-indigenous-kids-in-high-income-countries/2461421/Many urban-living Indigenous children and young people in high-income countries are burdened with atopic dermatitis and bacterial skin infections, according to Aasystematic analysis in Pediatric Dermatology. Investigators note that these conditions are intertwined, in that poorly managed atopic de…